Zengerling, F.; Streicher, W.; Schrader, A.J.; Schrader, M.; Nitzsche, B.; Cronauer, M.V.; Höpfner, M.
Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells. Int. J. Mol. Sci. 2012, 13, 11530-11542.
https://doi.org/10.3390/ijms130911530
AMA Style
Zengerling F, Streicher W, Schrader AJ, Schrader M, Nitzsche B, Cronauer MV, Höpfner M.
Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells. International Journal of Molecular Sciences. 2012; 13(9):11530-11542.
https://doi.org/10.3390/ijms130911530
Chicago/Turabian Style
Zengerling, Friedemann, Wolfgang Streicher, Andres J. Schrader, Mark Schrader, Bianca Nitzsche, Marcus V. Cronauer, and Michael Höpfner.
2012. "Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells" International Journal of Molecular Sciences 13, no. 9: 11530-11542.
https://doi.org/10.3390/ijms130911530
APA Style
Zengerling, F., Streicher, W., Schrader, A. J., Schrader, M., Nitzsche, B., Cronauer, M. V., & Höpfner, M.
(2012). Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells. International Journal of Molecular Sciences, 13(9), 11530-11542.
https://doi.org/10.3390/ijms130911530